Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats (Q84255817)
Jump to navigation
Jump to search
scientific article published on 01 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats |
scientific article published on 01 July 2011 |
Statements
Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats (English)
Lu Luo
De-Zai Dai
Yu-Si Cheng
Qi Zhang
Wen-Jun Yuan